Newsroom

Home / Newsroom

As the principal national public voice for ophthalmology in Canada, the Canadian Ophthalmological Society (COS) plays a critical role in advocating for optimal eye care for all Canadians.

Representing eye physicians and surgeons from coast to coast to coast, COS strategically collaborates with governments, industry partners and health care allies on a wide range of advocacy issues, including stronger vision standards, improved federal regulations, and shorter wait times for speciality eye surgeries.

For media enquiries, please contact:

Kim Tytler
Manager, Communications and Public Affairs
[email protected]
613.729.6779 x231

Thursday May 31, 2018

Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings

“The Canadian Ophthalmological Society suggests that the recommendations of the US Preventative Services Task Force (2016), namely no recommendation for or against screening, be adopted.”CMAJ

Wednesday May 16, 2018

What your eyes can tell you about your health

“Women are more susceptible to certain conditions that can present in the eyes, such as multiple sclerosis (MS) and thyroid dysfunction, says Setareh Ziai, an assistant professor of ophthalmology at the University of Ottawa Eye Institute.”MSN: Health and Fitness

Monday May 14, 2018

Everything you need to know about sun safety for kids

“Children’s eyes are particularly vulnerable to the sun’s UV rays, as their ocular lenses are still developing and cannot filter UV light in the same way as an adult’s can, Dr. Christine Law, a pediatric ophthalmologist and spokesperson for the Canadian Ophthalmological Society told HuffPost Canada.”Huff Post

Thursday May 10, 2018

Preventing and treating the leading cause of blindness for seniors: AMD

“It’s important we educate ourselves about AMD and the steps we can take to reduce vision loss with these tips from the Canadian Ophthalmological Society (COS) and Canadian Retina Society (CRS).”Forever Young

Wednesday May 2, 2018

Joint letter from COS, CGS, CRS, CUS, and CAPOS on atropine 1% discontinuation

Mr. Kyle SteigerVP Ophthalmology FranchiseNovartis Pharmaceuticals Canada Inc.385 Bouchard Blvd.Dorval QC H9S 1A9 Mr. Stu FowlerGM Alcon CanadaAlcon Canada Inc.2665 Meadowpine Blvd.Mississauga ON L5N 8C7 Dear Mr. Steiger and Mr. Fowler, Following the letter that the Canadian Ophthalmological Society (COS) sent you on March 26, 2018 regarding the impact Novartis/Alcon’s decision to discontinue Isopto Atropine […]

Tuesday May 1, 2018

Study shows only half of Canadians seek treatment for symptoms of potential eye disease that may lead to vision loss

The Canadian Ophthalmological Society sheds light onto Canadian eye health behaviours during National Vision Health Month A new survey, commissioned by the Canadian Ophthalmological Society (COS), revealed the majority of Canadians (59 per cent) experience symptoms of potential eye disease, yet only half of these people (54 per cent) reported they had seen a health […]